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Edited by Barry HalliwellAbstract Free radicals are a normal component of cellular oxy-
gen metabolism in mammals. However, free radical-associated
damage is an important factor in many pathological processes.
Glycation and oxidative damage cause protein modiﬁcations,
frequently observed in numerous diseases. Albumin represents a
very abundant and important circulating antioxidant. This
review brings together recent insights on albumin antioxidant
properties. First, it focuses on the diﬀerent activities of albumin
concerning protein antioxidation. In particular, we describe the
role of albumin in ligand binding and free radical-trapping activ-
ities. In addition, physiological and pathological situations that
modify the antioxidant properties of albumin are reported.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Oxidation1. Introduction
It is well established that free radicals and reactive oxygen
species (ROS), nitrogen, and chlorine species contribute to
the development of several age-related diseases by inducing
oxidative stress and oxidative damage. Oxidative stress is com-
monly deﬁned as a disturbance in the prooxidant and antiox-
idant balance leading to damage of lipids, proteins, and
nucleic acids [1]. Oxidative stress can result either from low lev-
els of antioxidants and/or from an increased production of
reactive species [2]. What is an antioxidant? Halliwell and
Whiteman deﬁned an antioxidant as ‘‘any substance that,
when present at low concentrations compared with those of
an oxidizable substrate, signiﬁcantly delays or prevents oxida-
tion of that substrate’’. The term ‘‘oxidizable substrate’’ corre-
sponds to ‘‘every type of molecule found in vivo’’ [2].Abbreviations: AGE, advanced glycation end products; ARDS, acute
respiratory distress syndrome; CML, N(epsilon)-(carboxymethyl)
lysine; H2O2, hydrogen peroxide; HSA, human serum albumin; LCFA,
long-chain fatty acids; LDL, low-density lipoprotein; NO, nitric oxide;
RAGE, receptor for advanced glycation end products; RNS, reactive
nitrogen species; ROS, reactive oxygen species
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doi:10.1016/j.febslet.2008.04.057Byproducts of oxygen metabolism, ROS, are reactive due to
the presence of unpaired valence shell electrons. Production of
ROS is not only intracellular but also concerns the surround-
ing area. Blood carries oxygen to tissues, and oxygen partial
pressure is about 100 mm Hg in the arterial circulation and
drops rapidly at the tissue levels with values between 4 and
20 mm Hg [3]. Then, blood is at least comparable, if not more
exposed to ROS than inside cells. Paradoxically, concentration
of antioxidants is much lower in plasma than in cells [4]. Sev-
eral models of oxidation indicate that albumin plays key role
in antioxidant functions challenging the historical idea that
only the intracellular compartment needs strenuous defense
against oxidants [4–9].2. Albumin, a multifunctional protein
Albumin contains 585 amino acids and has a molecular
weight of 66 kDa. This highly soluble protein is present in hu-
man plasma at normal concentrations between 35 and 50 g/l
(for a review see [10]). Albumin has several important physio-
logical and pharmacological functions. It transports metals,
fatty acids, cholesterol, bile pigments, and drugs. It is a key
element in the regulation of osmotic pressure and distribution
of ﬂuid between diﬀerent compartments. In normal conditions,
its half-life is about 20 days, and its plasma concentration rep-
resents equilibrium not only between its synthesis in the liver
and its catabolism, but also its transcapillary escape. In general,
albumin represents the major and predominant antioxidant in
plasma, a body compartment known to be exposed to continu-
ous oxidative stress. A large proportion of total serum antiox-
idant properties can be attributed to albumin. Previous works
have shown that more than 70% of the free radical-trapping
activity of serum was due to human serum albumin (HSA) as
assayed using the free radical-induced hemolysis test [11].
Usually, albumin concentrations remain very low in cerebro-
spinal, aqueous humor, and synovial and lung bronchoalveo-
lar lining ﬂuids when compared with plasma. Inﬂammation
enhances vascular permeability mainly through chemicals re-
leased by activated neutrophils [12]. A beneﬁcial eﬀect arises
from this apparent damage: albumin concentrations could be
found enhanced in sites of inﬂammation, for the protein to ex-
ert its multiple antioxidant properties [13].
In the next section, various activities of albumin as a major
antioxidant are examined. In the last section, some physiolog-
ical or pathological functions modifying the antioxidant prop-
erties of albumin are reported.blished by Elsevier B.V. All rights reserved.
Fig. 1. Main sites in albumin involved in its antioxidant activity. The
structure of albumin molecule is shown as strands using a PDB ﬁle
(PDB ID: 2BXF) of Ghuman et al. [61]. Lateral carbon chain of
residues involved in albumin antioxidant properties are developed and
colored. Amino terminus four amino acids of the protein are shown in
blue. This sequence is involved in the metal binding of the protein. The
sole free cysteine in the protein (Cys34) is shown in red. The free main
sites of ligation of PUFA in albumin are shown in purple. Lys240 in
albumin (yellow) is involved in bilirubin ligation. The six methionine
residues are depicted in green. Molecular graphic image was produced
using the UCSF Chimera package from the Resource for Biocomput-
ing, Visualization, and Informatics at the University of California, San
Francisco (supported by NIH P41 RR-01081).
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Albumin binds many types of molecules and was called a
‘‘sponge’’ or a ‘‘tramp steamer’’ of the circulation [10]. Many
antioxidant activities of albumin result from its ligand-binding
capacities. Albumin is well known for its ability to bind mole-
cules, such as metals ions, fatty acids, drugs, and also hor-
mones. The ﬂexibility of the albumin structure adapts it
readily to ligands, and its three domain design provides a vari-
ety of binding sites [10].
Among the cationic ligands, copper and iron deserve partic-
ular consideration because as transition metals, they are very
potent to generate ROS after a reaction with oxygen. Free
Cu(II) and Fe(II) ions can interact with hydrogen peroxide
(H2O2) leading to the formation of the deleterious hydroxyl
radical via the Fenton reaction. Bound to proteins, copper
and iron are generally less susceptible to participate in the Fen-
ton reaction. Concerning metals bound to albumin, hydroxyl
radicals released from Fenton reaction are mostly directed to
the protein sparing more important targets.
In plasma, most of the copper is bound to caeruloplasmin,
but a high percentage of the metal ion may exist bounded to
albumin [13]. HSA contains one high aﬃnity site for copper,
the N-terminal tripeptide Asp-Ala-His [14]. Protein sequestra-
tion of Cu(II) ions has been shown to prevent ROS-generating
reactions. The ﬁrst four amino acids of the N-terminus of hu-
man albumin, Asp-Ala-His-Lys (DAHK), form a tight-bind-
ing site for Cu(II) ions. Despite iron being present at higher
physiological concentrations, copper can react with H2O2 to
form hydroxyl radicals 60 times faster than iron [15]. Several
studies have shown the antioxidant property of albumin by
binding of copper using the copper-induced low-density lipo-
protein (LDL) oxidation assay [6,7,16,17]. In this assay,
DAHK inhibited LDL lipid peroxidation and DAHK/Cu
complex showed a superoxide dismutase-like activity by signif-
icantly preventing the formation of ROS [18]. Moreover, HSA
and the tetrapeptide occupying its N-terminus (DAHK) were
shown to prevent neuronal death in murine cortical cell cul-
tures exposed to oxidative stress generated by H2O2 and by a
mixture of copper and ascorbic acid [19].
Regarding iron, proteins involved in its transport are trans-
ferrin, caeruloplasmin, and lactoferrin. Nonetheless, high con-
centrations of circulating albumin indicate that the protein
might be able to scavenge some hydroxyl radicals produced
from iron reaction with H2O2 [13]. In addition, in iron-over-
load disease, a signiﬁcant amount of iron-bound albumin
was reported [20].
Among lipids, polyunsaturated fatty acids (PUFA) contrib-
ute largely to the pool of oxidizable biological compounds in
plasma. Albumin binds with high aﬃnity to long-chain fatty
acids (LCFA) and PUFAs. The three main sites responsible
for LCFA in albumin are shown in Fig. 1 [10]. There is no evi-
dence that PUFAs bound to albumin are protected from lipid
peroxidation. Nonetheless, the fact that eﬀective lipid-phase
antioxidants bind albumin (bilirubin and NO), indicates PU-
FAs bound to albumin, may be protected from oxidant-medi-
ated damage [21,22]. The binding of sterols by albumin is
weak, and the esteriﬁed or non-esteriﬁed forms of cholesterol
are carried in plasma by lipoproteins that are more speciﬁcally
designed for the task [10]. Cholesterol undergoes oxidation in
vitro and in vivo, forming biologically active derivatives
known as oxysterols [23]. Interestingly, oxysterols, unlike cho-lesterol, distribute almost equally between lipoproteins and the
lipoprotein-deﬁcient serum (LPDS); in LPDS, the protein with
which oxysterols are associated is albumin [24]. This higher
aﬃnity means that oxysterols carried by albumin are less rap-
idly released to cells than cholesterol. By this, albumin could
limit detrimental eﬀects of oxysterols on cells.
An indirect antioxidant activity of albumin comes from its
ability to transport bilirubin, which binds with high aﬃnity
to the molecule at Lys240 [25]. Such albumin-bound bilirubin
was shown to act as an inhibitor of lipid peroxidation [26]. Re-
cently, bilirubin, bound to albumin in the primary site, was
shown to protect a-tocopherol from damage mediated by per-
oxyl radicals [27] and to prolong the survival of human ventric-
ular myocytes against in situ-generated oxidative stress [28].
Another aspect of antioxidant activity of albumin may come
from its capacity to bind homocysteine, a sulfur-containing
amino acid, which results from the catabolism of methionine
residue. Elevated plasma homocysteine is a well-known risk
factor for atherosclerosis and may act through oxidation of
LDL [29].4. Free radical-trapping properties in albumin
HSA contains one reduced cysteine residue (Cys34) which,
due to the large amount of albumin in plasma, constitutes
the largest pool of thiols in the circulation [30]. In healthy
adults, about 70–80% of the Cys34 in albumin contains a free
sulphydryl group, the rest forms a disulﬁde with several com-
pounds like cysteine, homocysteine, or glutathione [30].
Through the reduced Cys34, albumin is able to scavenge
M. Roche et al. / FEBS Letters 582 (2008) 1783–1787 1785hydroxyl radicals [31]. Oxidation of Cys34 leads to the forma-
tion of sulfenic acid (RSOH), which is further oxidized to sul-
ﬁnic (RSO2H) or sulfonic acid form (RSO3H) [30,32]. Sulfenic
acid constitutes a central intermediate in both the reversible
and irreversible redox modulation by reactive species. Sulfenic
acid in HSA was recently involved in mixed disulﬁde forma-
tion, supporting a role of HSA-Cys34 as an important redox
regulator in extracellular compartments [32]. Reactive nitrogen
species (RNS) constitute nitrogen-centered species analogous
to ROS. Some RNS, such as nitric oxide (NO), contribute to
various biological processes. Other RNS, such as peroxynitrite
(ONOO), constitute powerful oxidants and nitrating species
[33]. The –SH group of albumin represents an important anti-
oxidant against peroxynitrite as thiol group was shown to be
oxidized to a sulfenic acid (HSA-SOH) [34]. Subsequently,
HSA-SOH can be converted to a disulﬁde and then back to
mercapto-albumin (HSA-SH) [22].
Methionine residues (six in HSA) also represent an oxida-
tion-sensitive amino acid in albumin [7,11]. Met is particularly
susceptible to oxidation and a wide variety of oxidants lead to
production of methionine sulfoxide [35]. Oxidation to sulfone,
which is the next step, is only obtained under drastic condi-
tions not occurring usually in biological systems. Methionine
sulfoxide can be reversed back to Met with mild reductants
or by methionine sulfoxide reductases, whereas sulfone
formation is biologically irreversible. Levine et al. observed
that preferential oxidation of exposed Met residues in en-
zymes, such as glutamine synthase, had little eﬀect on their bio-
logical function [36]. They proposed the very attractive
hypothesis that the oxidation and reduction cycle of Met resi-
dues in biological systems could serve as a ROS scavenging
system to protect proteins from extensive modiﬁcations
[36,37].
Finally, hypochlorous acid (HOCl) constituted a strong oxi-
dant compound. Activated phagocytes, such as neutrophils
and monocytes, release myeloperoxidase enzyme, which cata-
lyzes the formation of HOCl [38,39]. Albumin is able to scav-
enge HOCl preventing alteration of its preferential biological
target a1-antiprotease [13].5. Impairments in albumin antioxidant capacities after oxidation
As previously mentioned, the albumin molecule exerts sev-
eral antioxidant properties. These beneﬁcial properties rely
on the structure of the molecule. Damages in the albumin mol-
ecule and its antioxidant properties have been considered as
‘‘biologically insigniﬁcant’’ because of the large amount of this
protein in plasma [13]. In addition, damaged albumin mole-
cules was reported to be rapidly removed from circulation
and degraded [40]. However, recent reports showed that anti-
oxidant properties of impaired albumin may be related to
pathological conditions.
During its long lifetime (more than 20 days), an albumin
molecule makes about 15000 passes through the circulation
[10]. Albumin incurs some damage that aﬀects its antioxidant
properties. These modiﬁcations could occur in diabetes melli-
tus, which is one of the pathological condition associated with
early occurrence of vascular complications, together with func-
tional alterations of albumin [41]. In this complex pathology,
albumin undergoes increased glycation [41]. This phenomenoncorresponds to the non-enzymatic attachment of a glucose
molecule to a free primary amine residue. Amadori rearrange-
ment of the glycated protein gives rise to the deleterious ad-
vanced glycation end products (AGE) [42]. After showing
that albumin antioxidant property was modiﬁed following in
vitro glycation by methylglyoxal [43], Favier et al. showed
impairment of the antioxidant properties of serum albumin
in patients with diabetes [44]. The binding activity of glycated
HSA to copper was shown to be lower than that of non-glycat-
ed HSAs [45]. In vivo, the contribution of albumin concentra-
tions to the iron-binding antioxidant capacity was shown to be
markedly reduced in diabetes [46]. Glycation of HSA induced
a marked loss of antioxidant activity of this molecule to cop-
per-mediated oxidation of LDL [6]. Furthermore, glycated
albumin exacerbated copper-induced LDL oxidation, proba-
bly by the generation of superoxide [6,45]. In vivo, albumin
also transports tryptophan, the largest and the essential amino
acid [10]. Binding of Trp is reduced in glycated albumin [47]. In
addition, some impairments in the antioxidant properties of
albumin after glycation and/or oxidation of the molecule was
evidenced [6,7]. Recently, we showed that in vitro glycated
albumin enhanced oxidative damage in adipocytes from a pri-
mary culture [48,49].
Several receptors for AGEs, termed receptor for advanced
glycation end products (RAGE), initiate intracellular signaling
and enhance ROS formation in cells though its recognition
and binding of AGEs [50]. The accumulation of N(epsilon)-
(carboxymethyl)lysine (CML), a major antigenic AGE, was
implicated in tissue disorders, in hyperglycemia and in inﬂam-
mation [51]. Glycated albumin was shown to impair vascular
endothelial NO synthase activity in vivo in aortas of rabbit
[52]. Use of speciﬁc antibodies showed that these eﬀects were
mediated by CML and RAGE receptor [52]. The incubation
of glycated HSA with HOCl led to the formation of CML
[51]. The same group showed that ligand activity of AGE pro-
teins to scavenger receptors was dependent on their rate of
modiﬁcation by AGEs [53]. Recently, hypochlorite-modiﬁed
albumin was shown to colocalize with RAGE in the artery wall
and to promote expression of monocyte chemotactic protein-1,
promoting inﬂammatory complications in the arterial wall
[54]. A toxic eﬀect of glycated albumin was reported on
microglial cells associated with impairments in cellular proteo-
lytic systems [55]. Several studies has described the involve-
ment of AGEs in neurodegeneration [41,56,57].
A total of 30–40% of patients with diabetes develop nephr-
opathies that require hemodialysis treatment. Both dityrosine
and carbonyl contents were found increased in HSA isolated
from patients on hemodialysis [17]. Such HSA had impaired li-
gand-binding capacity [17]. Furthermore, impaired antioxi-
dant properties of HSA from these patients was determined
using two diﬀerent systems, namely copper-mediated oxidation
of human LDL and the free radicals-mediated hemolysis test
[17]. Quinlan and Gutteridge [58] described an important
occurrence in oxidative damages in patients with acute respira-
tory distress syndrome (ARDS). A beneﬁcial eﬀect of albumin
administration was evidenced by the resulting enhancement in
plasma thiol-dependent antioxidant status and in the reduction
in protein oxidative damage [59].
Alterations in antioxidant properties of HSA was very re-
cently identiﬁed in vivo in persons subject to obstructive sleep
apnea syndrome [60]. This impaired antioxidant activity was
1786 M. Roche et al. / FEBS Letters 582 (2008) 1783–1787associated with an enhanced glycation status of albumin in
persons presenting this sleep disorder.6. Conclusions
Albumin, the most abundant circulating protein in the plas-
ma, exerts important antioxidant activities. The molecule acts
through its multiple-binding sites and free radical-trapping
properties. In physiological or pathological conditions, func-
tion associated with changes in the redox status, the albumin
structure, and its beneﬁcial antioxidant properties can be al-
tered. In general, albumin constitutes the major plasma protein
target of oxidant stress. Kochs postulate that a biological
compound could constitute a causative agent in a disease ap-
pears to be fulﬁlled by oxidized albumin. If important beneﬁ-
cial actions are exerted by native albumin, very detrimental
eﬀects can be provoked by oxidized form of the protein and
acting as a biomarker of oxidative stress. Critically, adminis-
tration of albumin to patients with ARDS confers robust pro-
tection against oxidative stress and a favorable inﬂuence on
redox-signaling processes regulating inﬂammation.
Additional studies, especially in vivo, are needed to docu-
ment the modiﬁcations in albumin structure and antioxidant
properties in pathologic conditions. Albumin has not yet
showed all its secrets, and experiments are highly warranted
to achieve a better understanding of its important antioxidant
properties.
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